Prokarium
Oral vaccines for infectious diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€109—164m (Dealroom.co estimates Feb 2023.)
Company register number 06300883
London England (HQ), Newcastle upon Tyne England (founding location)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | - | - |
| % growth | 163 % | 316 % | (19 %) | (50 %) | (100 %) | - | - |
| EBITDA | (1.1m) | (1.1m) | (1.9m) | (3.7m) | (5.6m) | (7.2m) | (10.5m) |
| % EBITDA margin | (636 %) | (145 %) | (322 %) | (1224 %) | (1401618 %) | - | - |
| Profit | (1.3m) | (1.3m) | (2.2m) | (3.5m) | (5.3m) | (6.3m) | (9.0m) |
| % profit margin | (745 %) | (178 %) | (374 %) | (1151 %) | (1316205 %) | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$8.0m | Seed | ||
£400k | Grant | ||
N/A | - | ||
| N/A | £2.0m | Grant | |
* | €8.0m | Early VC | |
£4.9m | Early VC | ||
$21.0m | Series B | ||
* | N/A | $30.0m | Late VC |
| Total Funding | €70.4m | ||
Related Content
Recent News about Prokarium
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.